LL37 5mg
Human cathelicidin antimicrobial peptide researched for immune defence, wound healing, and tissue regeneration.
What is LL37?
LL37 (Cathelicidin) is a naturally occurring human antimicrobial peptide with potent immunomodulatory, anti-inflammatory, and tissue regenerative properties. It is researched for its potential to support immune defence, wound healing, and overall tissue health.
Key Features
- Broad-spectrum antimicrobial activity
- Dual immune modulation and tissue repair roles
- Well-characterised cathelicidin research profile
- High purity ≥98% verified by RP-HPLC
Mechanism of Action
LL37 disrupts bacterial membranes through electrostatic interactions and pore formation, while also modulating immune responses via TLR4 and FPRL1 receptor pathways. Research indicates roles in neutrophil recruitment, angiogenesis promotion, and epithelial cell migration for wound repair.
Research Applications
- Antimicrobial and immune defence research
- Wound healing and tissue repair studies
- Anti-inflammatory pathway investigation
- Skin barrier function and dermal health research
- Respiratory mucosal defence studies
Reconstitution Guide
Reconstitute with 2ml bacteriostatic water. Store at 2–8°C after reconstitution and use within 28 days.
Research Use Only. For research use only. Not for human or veterinary use. All products are intended solely for in vitro research and laboratory use. Helix Biotech does not endorse, encourage, or condone the use of any research compounds in humans or animals.
Research Tools
Related Products
View all
KLOW 80mg
Advanced research-grade peptide blend synthesised to pharmaceutical purity standards.
CU50 — GHK-Cu 50mg
Copper peptide complex — 50mg tripeptide-copper formulation for tissue and regeneration research.
Epithalon 10mg
Tetrapeptide research compound studied for telomere support and cellular longevity.